Title
Content
Comvita tight-lipped on whether potential investor is a rival
Kate McVicar
Mon, 23 Feb 2026
Hot Topic
EARNINGS
Mon 23 Feb 2026 03:37:13pm
MARKET MOVEMENTS
Powered by:
VIEW MORE
Gainers
/
No results, Market opens at 10.00 NZST
Data will show from 10.20 NZST
Data will show from 10.20 NZST
Decliners
/
No results, Market opens at 10.00 NZST
Data will show from 10.20 NZST
Data will show from 10.20 NZST
Gainers
/
No results, Market opens at 12.00 NZST
Data will show from 12.20 NZST
Data will show from 12.20 NZST
Decliners
/
No results, Market opens at 12.00 NZST
Data will show from 12.20 NZST
Data will show from 12.20 NZST
Mon 23 Feb 2026 03:37:13pm
MARKET MOVEMENTS
Top Story
Free News Alerts
Sign up to get the latest stories and insights delivered to your inbox – free, every day.
Latest News
Curious News
Mon, 23 Feb 2026
Simon Shepherd and Brent Edwards
Mon, 23 Feb 2026
Quick Takes
Livestock sales, milk futures boost Landcorp half year
State-owned farming company Landcorp, which trades as Pāmu, has reported an improved half-year result, boosted by revenue growth from sheep and beef operations.
Farm income for the six months to December was up 15% to $166 million, driven by a $21m increase in livestock sales.
Net operating profit of $20m was up from a $2m loss in the same period a year earlier, helped by an $11m gain from milk futures, up from an $11m loss in same period prior.
“Our improved production outcomes reflect continued better pasture utilisation, animal performance, and optimisation of farming systems, enabled by more consistent, data-led decision making and the ongoing adoption of digital technologies,” said chief executive Mark Leslie.
The bottom line net profit of $95m was mainly down to a $94m gain on the value of biological assets.
Landcorp manages 360,000ha over 112 farms. Livestock numbers are seasonal but, at balance date, included 636,588 sheep, 135,912 beef cattle, and 60,481 dairy cows.
Fisher & Paykel Healthcare boosts revenue, profit guidance
Listed respiratory healthcare company Fisher & Paykel Healthcare has updated its revenue and earnings guidance for the 2026 financial year after good growth across its full range of Hospital products during the second half.
It has boosted full-year guidance for operating revenue to $2.3 billion from a range of $2.17b to $2.27b previously, and full-year net profit to in the range of $450m to $470m from the prior range of $410m to $460m.
The updated guidance doesn’t include any potential refund of US tariffs paid to date during the 2026 financial year.
It’s still assessing the impact of the US Supreme Court announcing it has invalidated tariffs imposed by the US administration under the International Emergency Economic Powers Act, saying there were still uncertainties around the ruling.
A tariff update will be provided at the company’s full-year results in May. The impact of the 15% US tariff on hospital products sourced from NZ was 32 basis points in the first half.
close
Quick Takes
Mon 23 Feb 2026 03:36:31pm
MARKET MOVEMENTS
Latest News
Most Popular
Most Commented
Editor's picks
Featured
Analysis
Categories
